The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Astellas Pharma; MSD
Research Funding - Amgen; Astellas Pharma; MSD; Roche Pharma AG
Comprehensive characterization of PDL-1 and CTLA-4 in gastric cancer.
 
Hans Anton Schloesser
Travel, Accommodations, Expenses - Astellas Pharma
 
Uta Drebber
No Relationships to Disclose
 
Martin Thelen
No Relationships to Disclose
 
Michael Kloth
No Relationships to Disclose
 
Sasha Rothschild
Consulting or Advisory Role - Astellas Pharma; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Serono; Novartis; Pfizer; Roche Pharma AG
Research Funding - Astellas Pharma (Inst); Roche Pharma AG (Inst); Sanofi (Inst)
 
Maria Garcia-Marquez
No Relationships to Disclose
 
Sharam Zoghi
No Relationships to Disclose
 
Alexander Urbanski
No Relationships to Disclose
 
Hakan Alakus
No Relationships to Disclose
 
Astrid Schauss
No Relationships to Disclose
 
Sebastian Theurich
No Relationships to Disclose
 
Ute Warnecke-Eberz
No Relationships to Disclose
 
Dirk Ludger Stippel
No Relationships to Disclose
 
Arnulf Heinrich Hölscher
No Relationships to Disclose
 
Thomas Zander
Honoraria - Amgen; Lilly; Merck; Novartis; Roche Pharma AG; Sanofi
 
Stefan Paul Moenig
No Relationships to Disclose
 
Michael S. von Bergwelt-Baildon
No Relationships to Disclose